Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2003
10/30/2003US20030203236 OLEDs doped with phosphorescent compounds
10/30/2003US20030202959 Polymeric acyl derivatives of indoles
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482022A1 Novel compounds
10/29/2003EP1357185A1 4-[(3-methyl-2(3H)-benzothiazolyliden)methylene]-quinoline and -pyridine derivatives as reporter groups in probes for analysis of nucleic acids
10/29/2003EP1357124A1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
10/29/2003EP1357114A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP)
10/29/2003EP1357112A1 Novel functional peptide nucleic acid monomer and process for producing the same
10/29/2003EP1356813A1 Antibacterial compositions comprising metal phthalocyanine analogues
10/29/2003EP1355916A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/29/2003EP1355913A1 Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355904A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355651A2 Treatment of diabetes mellitus using vardenafil
10/29/2003EP1355649A2 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
10/29/2003EP1212324B1 Imidazo-triazine derivatives as ligands for gaba receptors
10/29/2003EP1185531B1 Cationic pyrrolo-pyrrol-derivatives, method for producing them and colorants for keratin fibres, containing these compounds
10/29/2003EP1147112B1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/29/2003EP0983272B1 A new class of benzoporphyrin derivative photoactive compounds
10/29/2003EP0916091B1 Light-sensitive compositions for oxygen optrodes
10/29/2003CN1452622A Piperzine devivs.
10/28/2003US6639076 Such as 2-(2-amino-2-methylpropanoylamino)-n-(1-(2-oxo-1-phenyl-2-pyrrolidinylethyl -4-yl)-4-phenylbutanamide
10/28/2003US6639074 Reacting an alpha -substituted ketone with a cyclic alkylenetetramine in solvent(s) to form a quaternary ammonium salt; reacting with acid in solvent(s) form an alpha -amino ketone; reacting with acyl derivative; dehydrating
10/28/2003US6639069 Method of preparing and uses of cucurbituril devices
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638937 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/28/2003US6638934 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist
10/28/2003US6638933 Bicyclic imidazo-3-yl-amine derivatives
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638925 Benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
10/28/2003US6638924 Metallotexaphyrin derivatives
10/28/2003CA2254521C New pyrrol derivatives, their method of preparation and pharmaceutical compositions containing these derivatives
10/28/2003CA2252701C Halo-substituted protein kinase c inhibitors
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087101A1 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles
10/23/2003WO2003087095A1 Quinolinone derivatives
10/23/2003WO2003087089A1 Piperidine derivatives having ccr3 antagonism
10/23/2003WO2003087064A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086464A1 Preventives/remedies for hotflash
10/23/2003WO2003086404A1 Fused quinoxaline derivatives as inhibitors of akt activity
10/23/2003WO2003086394A1 Inhibitors of akt activity
10/23/2003WO2003086393A1 3-aza- and 1,4-diaza-bicyclo[4.3.0]nonanes, and methods of use thereof
10/23/2003WO2003086315A2 Tyrosine kinase inhibitors
10/23/2003WO2003086306A2 5ht2c receptor modulators
10/23/2003WO2003043960A3 IMPROVED PURIFICATION OF 4, 4'(5')-DI-t-BUTYLCYCLOHEXANO-18-CROWN-6
10/23/2003WO2003002064A3 Fused pyrimidine dhfr inhibitors as antibacterials
10/23/2003US20030199552 Amide derivatives as NMDA receptor antagonists
10/23/2003US20030199541 topical bactericides and disinfectants for surgical instruments; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen; (SML pat indexing merged to app)
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199524 Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/23/2003US20030199515 Method for the preparation of crystalline tetrahydrobenzothiepines
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199502 Indoloquinazolinones
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003US20030199493 A dibenzofuranazepine derivatives for use as therapeutic treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, stroke, cerebral trauma
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199393 N- ([1,2,4,] triazoloazinyl) thiophenesulfonamide compounds and their use as herbicides
10/23/2003US20030198597 Measuring intensity of signal; calibration
10/23/2003CA2484261A1 Piperidine derivatives having ccr3 antagonism
10/23/2003CA2481391A1 Preventives/remedies for hotflash
10/23/2003CA2480860A1 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003CA2480856A1 Substituted aryl amides
10/23/2003CA2480758A1 Tyrosine kinase inhibitors
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1353925A2 Processes for large scale production of tetrapyrroles
10/22/2003EP1353924A1 Synthesis of temozolomide and analogs
10/22/2003EP1353923A1 Improved process for carbapenem synthesis
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353897A1 Method for producing dtpa monoamides
10/22/2003EP1353750A1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1200417B1 Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
10/22/2003EP0764167B1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
10/22/2003CN1451007A Adenosine A2A receptor antagonists
10/22/2003CN1451006A I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives
10/22/2003CN1450073A Process for extracting and puritying haem
10/22/2003CN1450066A Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant
10/22/2003CN1125071C Phthalocyanine and use of phthalocyanine as marking agent
10/22/2003CN1125070C Pyrrolo [2,3-d] pyrmidine compounds, and compositions and use thereof
10/22/2003CN1125069C Preparation of alkylthio-and/or arylthio-substd. diketo-diaryl-pyrrolopyrroles
10/21/2003US6635771 N-benzhydryl indole compounds
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635762 Monocyclic-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635647 Decahydro-isoquinolines
10/21/2003US6635645 2,5,-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses
10/21/2003US6635644 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003US6635626 Imidazoquinoxaline protein tyrosine kinase inhibitors
10/21/2003US6635620 Hydroxyproline derivatives
10/21/2003CA2222265C Dye compositions for keratinic fibers containing pyrazolo-¬1,5-a|-pyrimidine derivatives, dye processing, novel pyrazolo-¬1,5-a|-pyrimidine derivatives and their preparation process
10/16/2003WO2003084960A1 Cyclic compounds and the use thereof as light absorbers, light emitters, or complex ligands
10/16/2003WO2003084955A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/16/2003WO2003084926A2 Polymeric acyl derivatives of indoles
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 573